Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
BBI Ph1 TP-3654 and Ruxolitinb in patients with Intermediate and High Risk Myelofibrosis
Clinical Trial Grant
Duke Scholars
Principal Investigator
Lindsay Anne Magura Rein
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Sumitomo Dainippon Pharma Co.
Start Date
February 28, 2020
End Date
March 31, 2026
Awarded By
Sumitomo Dainippon Pharma Co.
Start Date
February 28, 2020
End Date
March 31, 2026
